Distributed by Mapi Research Trust
Distributed by Mapi Research Trust
Originally developed in 2006
The BREAST-Q™ includes separate modules: Reconstruction (including Expectations scales), Reduction/Mastopexy, Augmentation, Mastectomy, Breast Conserving Therapy, and Latissimus Dorsi (LD) Scales
WEBINAR: An Author Webinar on the BREAST-Q™ - Recorded session available here!
Pusic Andrea L; Cano Stefan; Klassen Anne F
Breast Surgery
PRO
Klassen AF, Pusic AL, Scott A, Klok J, Cano SJ. Satisfaction and quality of life in women who undergo breast surgery: a qualitative study. BMC Womens Health. 2009 May 1;9:11
Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009 Aug;124(2):345-53
Pusic AL, Chen CM, Cano S, Klassen A, McCarthy C, Collins ED, Cordeiro PG. Measuring quality of life in cosmetic and reconstructive breast surgery: a systematic review of patient-reported outcomes instruments. Plast Reconstr Surg. 2007 Sep 15;120(4):823-37 (Abstract)
Pusic AL et al. Measuring Quality of Life in Breast Surgery: Content Development of a New Modular System to Capture Patient-Reported Outcomes (The MSKCC Breast-Q). ISOQOL Annual Meeting, October 2006, Lisbon, Portugal
Pusic AL, Reavey PL, Klassen AF, Scott A, McCarthy C, Cano SJ. Measuring patient outcomes in breast augmentation: introducing the BREAST-Q Augmentation module. Clin Plast Surg. 2009 Jan;36(1):23-32
Pusic Andrea L; Cano Stefan; Klassen Anne F
Pusic Andrea L
Memorial Sloan-Kettering Cancer Center
1275 York Avenue
New York, NY 10065
USA
Phone: +1 (646) 888-3551
E-mail: pusica@mskcc.org
Andrea L Pusic publications (PubMed)
Cano Stefan J
Neurological Outcomes Measures Unit
Institute of Neurology
University College London
Queen Square, London WC1N 3BG
UK
Phone: +44 (020) 7837-3611 ext 3436
Fax: +44 (020) 7813-6505
Stefan J Cano publications (PubMed)
Klassen Anne F
Department of Pediatrics
3A HSC 1200 Main St W
Hamilton
Ontario
Canada
L8N 3Z5
Phone: +1 (905) 525-9140 x 73775
Fax: +1 (905) 524-5707
E-mail: aklass@mcmaster.ca
Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66
Academic Users
It is not necessary to contact the Memorial Sloan Kettering Cancer Center for academic clinical research. Just follow the steps below to get existing versions from Mapi Research Trust.
If you do not receive specific funding for your study, you can download the questionnaire directly from the 'Online distribution' tab in the left menu bar.
Commercial Users
A license agreement must be completed beforehand and a user fee is required.
Please contact:
Sue X. Yao
Office of Technology Development
Memorial Sloan Kettering Cancer Center
600 Third Avenue, 16th Floor,
New York, NY
USA
Phone: +1 646 888 1072
Email: yaox@mskcc.org or PusicA@mskcc.org
Then proceed with the steps below to get existing versions from Mapi Research Trust.
Translations and originals can be obtained from Mapi Research Trust:
| ROYALTY FEES* | Commercial users | Cost per study | Please contact rtmotdcontracts@mskcc.org |
| Cost per language | Please contact rtmotdcontracts@mskcc.org | ||
| Funded academic research | Cost per study | Free | |
| Cost per language | Free | ||
| Not funded academic users | Cost per study | Free | |
| Cost per language | Free |
| DISTRIBUTION FEES* | Commercial users | Cost per study | 1 500 € |
| Cost per language | 2 000 € | ||
| Funded academic research | Cost per study | Free | |
| Cost per language | Free | ||
| Not funded academic users | Cost per study | Free | |
| Cost per language | Free |
* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds
Additional information on the BREAST-Q website
Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.
Should you not correspond to this category of users, please send us a request.
Note: This site aims at providing you with the original version and existing translations of the questionnaire. However some modules/versions may not be downloadable in the language you need.
If you are interested in specific language(s), please first consult the list of existing translations in PROQOLID.
To access this section, please complete a client account.
The translations listed may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.
The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.
For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).
If you wish to translate the questionnaire:
Note that the author of the questionnaire requires to be involved in the translation process.
Subscribe to PROQOLID™
And get access to advanced descriptions of Clinical Outcome Assessments (COAs)!
SubscribePurchase a limited access to this COA instrument page
This will allow you to view this specific COA page during one active session of 12 hours max starting at your first attempt. Note that if your session is inactive for four hours, your access will be closed.